Entera Bio Ltd. (ENTX) Tops Q2 EPS by 5c

Entera Bio Ltd. (NASDAQ: ENTX) reported Q2 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Entera Bio Ltd. (ENTX) click here.

You May Also Be Interested In

• Wall Street's new pair trade: Long software, short chips
• Keycorp Sees Fy26 Revenue Up About 8%, Saw 7% To 8%
• FDA grants RMAT designation to Tenaya's TN-401 heart gene therapy